| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0035-9203(01)90104-X |
| P698 | PubMed publication ID | 11816438 |
| P2093 | author name string | Artemether-Quinine Meta-analysis Study Group | |
| P2860 | cites work | Randomized comparison of intramuscular artemether and intravenous quinine in adult, Melanesian patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea | Q46329652 |
| Artemether for severe malaria: a meta-analysis of randomized clinical trials | Q47845635 | ||
| A trial of artemether or quinine in children with cerebral malaria | Q48027993 | ||
| An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children | Q48030403 | ||
| The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study | Q48037061 | ||
| Neurotoxicity in animals due to arteether and artemether | Q48112147 | ||
| Behavioral and Neural Toxicity of Arteether in Rats | Q48445818 | ||
| Dose-Dependent Brainstem Neuropathology Following Repeated Arteether Administration in Rats | Q48555194 | ||
| Arteether: risks of two-week administration in Macaca mulatta | Q48736960 | ||
| Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
| Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa | Q39111480 | ||
| Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand | Q39121176 | ||
| Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice | Q39308526 | ||
| A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria | Q39532225 | ||
| Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria | Q40641696 | ||
| An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children | Q40713335 | ||
| The effect of mefloquine-artemether compared with quinine on patients with complicated falciparum malaria | Q40790665 | ||
| A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria | Q40801623 | ||
| Seasonal variation of paediatric diseases in The Gambia, West Africa | Q41938963 | ||
| African children with malaria in an area of intense Plasmodium falciparum transmission: features on admission to the hospital and risk factors for death | Q43952102 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| artemether | Q416199 | ||
| patient | Q181600 | ||
| meta-analysis | Q815382 | ||
| malaria | Q12156 | ||
| P304 | page(s) | 637-650 | |
| P577 | publication date | 2001-01-01 | |
| 2001-11-01 | |||
| P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
| ??? | http://www.wikidata.org/.well-known/genid/7add2aabf75e0b7e4d4b1d4604956b4e | ||
| P1476 | title | A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria | |
| P478 | volume | 95 |
| Q41856126 | A Brief History of Qinghaosu |
| Q33979671 | Antiepileptic properties of Quinine: A systematic review |
| Q22061779 | Antimalarial Drug Toxicity |
| Q35840382 | Antimalarial combinations |
| Q36652599 | Antimalarial drug therapy: the role of parasite biology and drug resistance |
| Q38573032 | Antimicrobial prevention and therapy for travelers' infection. |
| Q34230161 | Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria |
| Q24193663 | Artemether for severe malaria |
| Q69347181 | Artemether for severe malaria. |
| Q24200839 | Artemether intramuscular injection for severe malaria in children |
| Q34622342 | Artemisinin Antimalarials: Preserving the "Magic Bullet" |
| Q33908825 | Artemisinin derivatives for treating severe malaria |
| Q34114331 | Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review |
| Q56772781 | Artemisinins in malaria treatment in the UK |
| Q34509744 | Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea |
| Q21032520 | Artesunate versus quinine for treating severe malaria |
| Q24235937 | Artesunate versus quinine for treating severe malaria |
| Q24242928 | Artesunate versus quinine for treating severe malaria |
| Q24244022 | Artesunate versus quinine for treating severe malaria |
| Q33222370 | Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial |
| Q24630683 | Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial |
| Q36777830 | Artesunate, artemether or quinine in severe Plasmodium falciparum malaria? |
| Q33678047 | Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria |
| Q36945007 | Assessment of safety of the major antimalarial drugs |
| Q48030862 | Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo |
| Q36889570 | Cardiotoxicity of antimalarial drugs |
| Q35043526 | Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand. |
| Q37598749 | Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria |
| Q46967638 | Comparison of the effectiveness of artemether and quinine for treatment of severe malaria in children, Bangui, Central African Republic |
| Q21032462 | Critical Care Aspects of Malaria |
| Q44897666 | Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. |
| Q37492591 | Existing antimalarial agents and malaria-treatment strategies |
| Q33346152 | Life-threatening Plasmodium falciparum parasitemia, in an infant returning from the tropics |
| Q34714939 | Malaria and the lung |
| Q34807496 | Malaria: Current status of control, diagnosis, treatment, and a proposed agenda for research and development |
| Q34873513 | Malaria: an update on treatment of adults in non-endemic countries. |
| Q56771228 | Malaria: severe, life-threatening |
| Q33448223 | Malaria: severe, life-threatening. |
| Q31016826 | Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. |
| Q39067045 | Neuropathological assessment of artemether-treated severe malaria |
| Q35581916 | New Antimalarial Drugs |
| Q36317580 | Pathogenesis, clinical features, and neurological outcome of cerebral malaria |
| Q26830528 | Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization |
| Q36778732 | Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen |
| Q21032496 | Qinghaosu (Artemisinin): The Price of Success |
| Q17485067 | Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria |
| Q40535234 | Randomized control trial of quinine and artesunate in complicated malaria |
| Q33864553 | Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria |
| Q36402677 | Research priorities in the management of severe Plasmodium falciparum malaria in children |
| Q37242654 | The antiviral activities of artemisinin and artesunate. |
| Q44323095 | The management of severe falciparum malaria |
| Q33592955 | The murine cerebral malaria phenomenon |
| Q34619100 | The treatment of severe malaria |
| Q37693152 | Toxicity of the antimalarial artemisinin and its dervatives. |
| Q34456393 | Treating severe malaria in pregnancy: a review of the evidence |
| Q36723819 | Treatment of childhood Plasmodium falciparum malaria: current challenges |
| Q38907878 | UK malaria treatment guidelines 2016. |
| Q95301695 | Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries |
| Q79328093 | [Antiparasite therapy] |
Search more.